Another potential non-invasive biomarker for PCa is represented by the presence of methylated GSTP1 DNA in plasma and serum of PCa patients; this epigenetic status was associated with prognosis, advanced AJCC tumor stage, PSA recurrence after surgery and response to chemotherapy. Here, KLK3 is linked to neoplasm.